[Form 4] OMNICELL, INC. Insider Trading Activity

Rhea-AI Filing Summary

Corey J. Manley, Executive Vice President & Chief Legal/Administrative Officer of Omnicell, Inc. (OMCL), reported a sale of 3,880 shares of Omnicell common stock on 09/12/2025 at a price of $33.25 per share. After the transaction, Mr. Manley beneficially owned 110,653 shares, held directly. The filing notes the sale was made pursuant to a pre-established Rule 10b5-1 trading plan adopted on June 13, 2025. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Manley on 09/16/2025.

Positive

• Sale disclosed promptly on Form 4, meeting Section 16 reporting requirements
• Transaction executed under a Rule 10b5-1 trading plan, indicating a pre-established, compliant disposition

Negative

• Insider reduced direct holdings by 3,880 shares to 110,653 shares following the sale

Insights

Securities Analyst

TL;DR: Insider sold a small block under a 10b5-1 plan; transaction is routine and fully disclosed.

The sale of 3,880 shares at $33.25 under a Rule 10b5-1 plan indicates a pre-authorized disposition rather than ad hoc trading. The post-sale beneficial ownership of 110,653 shares remains significant enough to align executive incentives with shareholders. The disclosure meets Section 16 requirements and reduces information asymmetry for investors. There is no additional company-specific financial data in this Form 4 to infer performance implications.

Corporate Governance Expert

TL;DR: Governance controls appear in place; the trade was executed under an established trading plan and timely reported.

The filing documents an officer-level sale executed through a 10b5-1 plan adopted June 13, 2025, which supports compliance with insider trading rules. Timely electronic reporting and signature by an attorney-in-fact on 09/16/2025 reflect procedural adherence. The Form 4 contains no indications of unusual or unexplained transactions that would raise governance concerns based on the information provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Manley Corey J

(Last) (First) (Middle)

OMNICELL, INC.

4220 NORTH FREEWAY

(Street)

FORT WORTH TX 76137

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
OMNICELL, INC. [ OMCL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP&CHIEF LEGAL/ADMIN OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/12/2025		S		3,880	D(1)	$33.25	110,653	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.

	/s/ Vijay Biligiri, Attorney in Fact for Corey J. Manley	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did OMCL insider Corey J. Manley report on Form 4?

The filing reports a sale of 3,880 shares of Omnicell common stock on 09/12/2025 at $33.25 per share.

Was the sale by OMCL insider Corey J. Manley part of a trading plan?

Yes. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on June 13, 2025.

How many OMCL shares does Corey J. Manley own after the reported transaction?

After the transaction, Mr. Manley beneficially owned 110,653 shares, held directly.

What price did the OMCL shares sell for in the reported transaction?

The reported sale price was $33.25 per share.

Who signed the Form 4 for Corey J. Manley and when?

The Form 4 was signed by Vijay Biligiri, Attorney in Fact for Corey J. Manley on 09/16/2025.